NIH

Two Popular Diabetes Drugs Outperformed Others in Massive Clinical Trial

Two Popular Diabetes Drugs Outperformed Others in Massive Clinical Trial

Press release Wednesday, September 21, 2022 NIH-funded researchers complete first study comparing drugs commonly used for type 2 diabetes. In a large clinical trial directly comparing four drugs commonly used to treat type 2 diabetes, researchers found that insulin glargine and liraglutide were the best of the four drugs approved by the United States Food …

Two Popular Diabetes Drugs Outperformed Others in Massive Clinical Trial Read More »

Prenatal cannabis exposure associated with mental disorders in children that persist into early adolescence

Prenatal cannabis exposure associated with mental disorders in children that persist into early adolescence

Media Advisory Monday, September 12, 2022 NIH-funded findings add to growing scientific evidence of negative health effects of cannabis use during pregnancy What Prenatal exposure to cannabis after the middle of the first trimester – typically after five to six weeks of fetal development – ​​is associated with attentional, social and behavioral problems that persist …

Prenatal cannabis exposure associated with mental disorders in children that persist into early adolescence Read More »